Insulin-like growth factors and liver cancer risk in male smokers

British Journal of Cancer

Volumn 103, Issue 7, 2010, Pages 1089-1092

  Major, J M ^a   Stolzenberg Solomon, R Z ^a   Pollak, M N ^b   Snyder, K ^c   Virtamo, J ^d   Albanes, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

IGF I; incidence; insulin like growth factor; men

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; LIVER CARCINOMA; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; BLOOD; INCIDENCE; LIVER TUMOR; METABOLISM; MIDDLE AGED; RISK; SMOKING;

HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK; SMOKING;

EID: 77957242251     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605842     Document Type: Article

References (34)

1. Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1): S5-S16 (Pubitemid 39423365)
2. Buzzelli G, Dattolo P, Pinzani M, Brocchi A, Romano S, Gentilini P (1993) Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm. Am J Gastroenterol 88(10): 1744-1748 (Pubitemid 23298126)
3. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279(5350): 563-566 (Pubitemid 28067285)
4. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94(14): 1099-1106 (Pubitemid 34830730)
5. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57(21): 4667-4672 (Pubitemid 27468963)
6. Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM (2006) Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clin Biochem 39(6): 623-629 (Pubitemid 43912171)
7. Ferry Jr RJ, Katz LE, Grimberg A, Cohen P, Weinzimer SA (1999) Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res 31(2-3): 192-202 (Pubitemid 29169496)
8. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression, 2nd edn Wiley: New York
9. Iivonen J, Kela E, Kuusi M, Lyytikainen O, Ruutu P (2005) Infectious Diseases in Finland 1995-2004. National Public Health Institute: Helsinki
10. Jewell NP (2004) Statistics for Epidemiology. Chapman & Hall/CRC: Boca Raton
11. Juul A (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13(4): 113-170 (Pubitemid 36986557)
12. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort- accuracy and delay. Acta Oncol 41(4): 381-388
13. London T, McGlynn K (2006) Liver Cancer, 3rd edn Oxford University Press: Oxford, New York
14. Lonn S, Inskip PD, Pollak MN, Weinstein SJ, Virtamo J, Albanes D (2007) Glioma risk in relation to serum levels of insulin-like growth factors. Cancer Epidemiol Biomarkers Prev 16(4): 844-846 (Pubitemid 46650593)
15. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91(7): 620-625 (Pubitemid 29194048)
16. Major JM, Pollak MN, Snyder K, Virtamo J, Albanes D (2010) Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer 103(1): 132-135
17. Mattera D, Capuano G, Colao A, Pivonello R, Manguso F, Puzziello A, DAgostino L (2003) Increased IGF-I: IGFBP-3 ratio in patients with hepatocellular carcinoma. Clin Endocrinol (Oxf) 59(6): 699-706 (Pubitemid 37491573)
18. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C (2002) Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer 95(12): 2539-2545 (Pubitemid 35424040)
19. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni Jr JF (2001) International trends and patterns of primary liver cancer. Int J Cancer 94(2): 290-296 (Pubitemid 32911426)
20. Moschos SJ, Mantzoros CS (2002) The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63(4): 317-332 (Pubitemid 36151524)
21. Pavelic J, Matijevic T, Knezevic J (2007) Biological & physiological aspects of action of insulin-like growth factor peptide family. Indian J Med Res 125(4): 511-522 (Pubitemid 47099107)
22. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12): 1373-1379 (Pubitemid 27028925)
23. Pollak M (2000) Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36(10): 1224-1228 (Pubitemid 30407009)
24. Renehan AG, Zwahlen M, Minder C, ODwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418): 1346-1353 (Pubitemid 38529873)
25. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124(10): 2416-2429
26. Sachdev D, Yee D (2007) Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther 6(1): 1-12 (Pubitemid 46206663)
27. Scharf JG, Braulke T (2003) The role of the IGF axis in hepatocarcinogenesis. Horm Metab Res 35(11-12): 685-693 (Pubitemid 38058172)
28. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5(9): 558-567 (Pubitemid 41196755)
29. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112-125 (Pubitemid 44289094)
30. Stuver SO, Kuper H, Tzonou A, Lagiou P, Spanos E, Hsieh CC, Mantzoros C, Trichopoulos D (2000) Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer 87(1): 118-121 (Pubitemid 30368424)
31. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 4(1): 1-10 (Pubitemid 24102333)
32. Woodward M (2005) Epidemiology: Study Design and Data Analysis, 2nd edn Chapman & Hall/CRC: Boca Raton
33. Wu JC, Daughaday WH, Lee SD, Hsiao TS, Chou CK, Lin HD, Tsai YT, Chiang BN (1988) Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 112(5): 589-594
34. Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11(8): 705-712 (Pubitemid 34851903)